N
icotinic acetylcholine receptors are a class of pentameric ligand-gated ion channels present in the central and peripheral nervous systems (1) (2) (3) (4) . Different subtypes of these channels are involved in neuromuscular, autonomic, and CNS neurotransmission (2) . Nicotinic receptors may be involved in number of diseases, including Alzheimer's and Parkinson's diseases, schizophrenia, Tourette's syndrome, and certain epilepsies, as well as nicotine addiction. Additionally, nicotinic receptor agonists have potential as analgetics, anxiolytics, and nootropics (3) (4) (5) (6) (7) . Nicotinic agonists and antagonists used in the present study are shown in Fig. 1 .
Methods of pharmacologic analysis of nicotinic receptors have included both radioligand binding assays (8) (9) (10) (11) and functional assays (12) (13) (14) (15) (16) . Whereas binding assays are rapid and relatively simple to perform, they fail to distinguish agonists from antagonists. Functional assays for ion channels include classical electrophysiology (12, 17) , radioisotopic ion flux (13) (14) (15) , and fluorescent assays using ion-or voltage-sensitive dyes (16, (18) (19) (20) . In the current study, nicotinic receptor activation was measured by using a membrane potential-sensitive fluorescent dye (21, 22) as an indicator of ionic flux in cell lines expressing various nicotinic receptor subtypes, both native (8, 23, 24) and transfected (25, 26) . This result was compared with measurements using a calcium-sensitive dye. The membrane potential assay provides a rapid and sensitive method for the assessment of nicotinic responses. Indeed, readily quantifiable membrane potential responses were obtained in cell lines in which significant calcium responses could not be detected. Moreover, this method affords kinetic data, and allows measurement of agonism and antagonism within the same experiment. The paradigm used here may also be used to investigate loss of nicotinic response. This loss of response can reflect desensitization, in which the receptor becomes unresponsive to agonist (27, 28) , or open channel block at high agonist concentrations (29, 30 ). Membrane depolarization is undoubtedly an important cell-signaling event for ligand-gated ion channels, as this provides a trigger for activation of voltage-sensitive ion channels. Kinetic fluorescence measurements thus provide a valuable approach for measuring and understanding drug actions at nicotinic receptors as well as for high-throughput screening.
Materials and Methods
Reagents. All chemicals and reagents were obtained from commercial sources. ABT-418 hydrochloride was a gift of Abbott. It and (S)-nicotine di-D-tartrate, mecamylamine hydrochloride, (Ϯ)-epibatidine dihydrochloride, (7R,9S)-cytisine, 1,1-dimethyl-4-phenylpiperazinium iodide, A-85380 dihydrochloride, RJR-2429 dihydrochloride, (Ϯ)-epiboxidine hydrochloride, dihydro-␤-erythroidine hydrobromide, and (1R,6R)-(ϩ)-anatoxin-a fumarate were prepared as 1-mM or 10-mM stock solutions in methanol. Ionomycin-free acid and carbonyl cyanide, p-(trifluoromethoxy)phenylhydrazone (FCCP) were prepared as stock solutions in DMSO.
Buffers. Hanks' balanced salt solution (HBSS) was prepared from commercial 10ϫ stock (without sodium bicarbonate or phenol red) and supplemented with 20 mM 4-hydroxyethyl-1-piperazinesulfonic acid (Hepes) and adjusted to pH 7.4 with sodium hydroxide.
Dyes. Calcium ion and membrane potential dyes were obtained from Molecular Devices. Calcium ion dye solution was prepared by dissolving the contents of one bottle of the dry reagent in HBSS͞Hepes to a volume of 15 ml. Membrane potential dye solution was prepared in identical fashion, with dilution to 36 ml in HBSS͞Hepes. In our hands, these were the maximum useful dilutions for the cells studied here. The dye solutions were kept in the dark and were stable at least 8 h at room temperature and 2 wk in a Ϫ20°C freezer.
The no-wash dyes are of proprietary composition (31) . The responses are sensitive to dye concentration and loading time, as are other intensity dyes. The efficiency of dye loading was quite good in all lines reported here, allowing a reduction in dye usage of 5-to 12-fold relative to recommended loading described in package literature without substantial degradation of response characteristics. Further dilution, however, led to signal artifacts. expressing human ganglionic (9, 23) receptors, were obtained from the American Type Culture Collection.
Cell Culture. All cell lines were maintained in a culture medium consisting of Dulbecco's modified Eagle's medium supplemented with 10% FBS, 100 units͞ml penicillin, and 100 g͞ml streptomycin. KX␣3␤4R2, KX␣4␤2R2, and KX␣4␤4R1 cells were further supplemented with 0.6 mg͞ml genetecin. K-177 cells were further supplemented with 0.6 mg͞ml genetecin and 90 g͞ml hygromycin-B. Cells were maintained in an atmosphere of 5% CO 2 in a humidified incubator at 37°C and were subcultured weekly at a subcultivation ratio of between 1:20 and 1:100. For assays, 96-well plates were coated by treatment with 50 l per well of a sterile solution of 50 g͞ml poly-D-lysine (30-70 kDa) for 1 h followed by aspiration and washing with 75 l of sterile water and allowing the plates to dry in a laminar flow hood. Cells were seeded into these plates at a subcultivation ratio of between 1:2 and 1:4 and grown to near confluence in 75 l of culture medium. IMR-32 cells were seeded into 96-well plates precoated with collagen type I (Becton Dickinson) to improve cell attachment and reduce fibroblast populations (38) .
Calcium Fluorescence Measurements. The method used for analysis was an adaptation of the method for fluo-3 calcium measurements (18) . Sample plates for dose-response analysis were prepared by evaporation of an appropriate volume of methanolic stock solution in 96-well round-bottomed plates and reconstitution in HBSS͞Hepes, followed by serial dilution to produce 270 l of sample volume, sufficient for 3 to 4 assays, and sealed with parafilm until use. All reagents and test compounds were stored at Ϫ20°C when not in use. Cell cultures in 96-well plates were removed from the incubator, allowed to reach room temperature over the course of 10 min, and then washed twice with 100 l of HBSS͞Hepes. Subsequently, the medium was replaced with 30 l of calcium ion dye solution, and the cells were loaded for 1 h in the dark, after which plates were read on a Flexstation fluorescence plate reader (Molecular Devices). Excitation and emission wavelengths were set to 485 nm and 525 nm, respectively, with a cutoff of 515 nm. Measurements were made at 1-to 1.5-s intervals. Basal fluorescence was measured for 15- Compound response
Absolute calcium concentrations were not determined, as these tend to be unreliable with intensity dyes.
Membrane Potential Measurements. This assay was conducted in a similar fashion to the calcium assay, with modifications. Briefly, cells were equilibrated and washed as before, followed by loading for 45 min with 30 l of membrane potential dye solution. Fluorescence measurements were taken as before, but with excitation and emission wavelengths set to 535 nm and 560 nm, respectively, and with a cutoff of 550 nm. Finally, the ionomycin͞ carbachol͞FCCP calibrant solution was replaced by a 4ϫ calibrant solution containing 160 mM KCl. Responses were calculated as before with KCl serving as the calibrant, clamping the membrane potential to ϷϪ35 mV. In a few cases, especially when the dye concentration is low, a slowly dropping baseline was observed. In such cases, the baseline is taken as that immediately before the nicotine addition.
Data Analysis. Responses were normalized to the maximum response of (Ϯ)-epibatidine and fitted to a standard four parameter logistic equation. Data were either fitted within the F LEXSTATION control software or exported to PRISM (V. 3.0, GraphPad, San Diego). In cases where bell shaped curves were observed, data points on the ascending side were used for determination of potency and efficacy. Hill coefficients were typically one or greater; however, the number of concentration points did not allow for reliable measurements of this parameter.
Results
The general protocol of this method involved acquisition of a basal signal, followed by addition of the test compound to assess agonist potency (EC 50 ) and efficacy. Subsequently, a reference agonist (nicotine) was added to assess antagonism of the nico- tine reference response (IC 50 ). Such antagonism may be either the result of open channel blockade or desensitization (27) (28) (29) (30) . In the cell lines tested, however, time-dependent desensitization did not seem to contribute significantly within the time frame of the experiment (see below). Finally, a calibrant was added to normalize for dye loading and cell count. This protocol resulted in a signal having three distinct phases as illustrated for epibatidine and nicotine in Fig. 2 .
After subtraction of basal fluorescence, the response was calculated as the ratio of the fluorescence increase produced by the test compound to that produced by the calibrant. The nicotine reference response was calculated in a similar fashion. Response values were then normalized to the percentage of the maximum (Ϯ)-epibatidine response for activation, or the nicotine reference response for inhibition, resulting in concentrationresponse curves as shown in Fig. 3 . In KX␣3␤4R2 cells, EC 50 values for activation were similar to IC 50 values for inhibition of the nicotine reference response as shown in Table 1 . This result is consistent with a simple saturation mechanism, because the subsequent response of an already stimulated system should be reduced relative to an unstimulated one. The timescale of the experiment is short relative to the desensitization periods for the receptor subtypes assessed in this study (27) . Indeed, the IC 50 for nicotine did not change from 30 s up to 1 h of preexposure in KX␣3␤4R2 cells (data not shown). However, during the time course of the usual assays, the agonist-evoked signal did not decay entirely in the calcium dynamics experiments. Often in the case of membrane potential, the agonist signal did not decay at all (see Fig. 2 ). Thus, the derived IC 50 values based on apparent reduction of the subsequent nicotine signal should be viewed with caution.
To evaluate the utility of membrane potential fluorescence for evaluation of nicotinic pharmacology, data obtained for several nicotinic agonists and antagonists were compared with parallel data from calcium fluorescence and published data for 86 Rb efflux (30) for KX␣3␤4R2 cells ( Table 2 ). As shown in Fig. 4 , compounds show a similar rank order of potency although agonists seem more potent in the membrane potential assay than either calcium fluorescence or 86 Rb efflux assays. Two nicotinic antagonists, mecamylamine and dihydro-␤-erythroidine, were also assessed, and were less potent in the membrane potential assay than in calcium or 86 Rb efflux assays. Calcium fluorescence and 86 Rb efflux yielded very similar values for potency as observed previously (16, 30) .
A number of cell lines expressing a variety of nicotinic receptor subtypes were next evaluated. The K-177, IMR-32, SH-SY5Y, and TE-671 cells gave only weak signals by using calcium fluorescence, whereas KX␣4␤2R2, and KX␣4␤4R1 cells gave no detectable signal (data not shown). In contrast, quantifiable signals were obtained with all cell lines by using membrane potential (Table 3) . Nicotine responses in both assays were blocked by mecamylamine in all cell lines tested. IC 50 values are reported for both antagonists and agonists in Table 3 , although IC 50 values for agonists should be viewed with caution (see above). Fluorescent membrane potential assays thus provide results consistent with nicotinic activation in a variety of cell types, and are clearly more sensitive than the corresponding calcium assays.
Discussion
High-throughput screening has led to miniaturization of assays and adaptation for screening large numbers of compounds in drug discovery and development efforts. Among the functional assay techniques for such screening, fluorescence has attracted much attention of late (16, (18) (19) (20) (21) (22) . The most widely used fluorescent probes for nicotinic receptor functional analysis have been the calcium chelating Fluo-and Fura-dyes developed by Tsien (39) (40) (41) . The calcium kit dye used in this study is similar in nature to the Fluo-3,4 intensity dyes, except that a secondary dye is incorporated to mask background fluorescence due to unloaded and extruded dye (31) . This masking dye eliminates the need for washing out extracellular dye, thus simplifying the assay and enhancing reproducibility.
The present methods allow for rapid screening of compounds for evaluation of structure-activity and subtype specificity relationships for nicotinic receptors. The 96-well instrument used in the current study has an integrated fluidics module that dispenses reagents during acquisition of signal. Up to three additions can be programmed, which allows acquisition of responses from the compound to be tested, a reference agonist, and the calibrant. This protocol allows agonist and antagonist activity to be assessed within the same experiment, because an agonist will produce an initial fluorescence response, whereas an antagonist will not. However, both will produce an inhibition of subsequent nicotine stimulation. The inhibition observed for nicotinic agonists could result from desensitization or open channel blockade (27) (28) (29) (30) . EC 50 and IC 50 values for the agonists were similar in magnitude in KX␣3␤4R2, KX␣4␤4R1, and TE-671 cells. In IMR-32, SH-SY5Y, and K-177 cells, IC 50 values for inhibition of the nicotine response by cytisine were significantly higher than EC 50 values for cytisine activation. Curiously, KX␣4␤2R2 cells required lower concentrations for inhibition of nicotine response than for activation by all four agonists (Table 3) . Further kinetic studies are required to reveal the reasons for such results, because the agonist responses had often not fully decayed before subsequent addition of the reference agonist, nicotine. Whereas the pharmacological interpretation of inhibition curves for agonists is not clear, they may serve as a diagnostic tool for nicotinic activity. In the case of antagonists, inhibition parameters will depended on the mechanism and time course of blockade.
The current paradigm provides kinetic data and allows for assessment of agonism and antagonism within the same experiment. The use of dyes that do not require washing reduces variability due to cell detachment. Finally, the use of an automated plate reader͞liquid handler increases reproducibility of additions. The membrane potential assay seems much more sensitive than the calcium fluorescence assay, but provides data consonant with either calcium fluorescence or 86 Rb efflux assays (Table 2 and Fig. 4) .
Although fluorescence measurement of nicotinic receptor activity through calcium dynamics has been documented extensively in recent years (16, (18) (19) (20) 31) , the use of membrane potential for nicotinic receptors is novel and quite sensitive. The use of membrane potential is especially important for cell lines that pass little or no calcium. TE-671 cells, expressing the neuromuscular subtype of nicotinic receptor (8) , have a low calcium conductance and expression. Indeed, we were unable to obtain a significant calcium response until well past cell conflu- Rb efflux, did not provide identical data. Agonists were consistently and significantly more potent in the membrane potential assay, whereas antagonists were less potent. Moreover, the potency of mecamylamine in KX␣3␤4R2 cells was Ϸ20-to 40-fold less than in IMR-32 or SH-SY5Y cells, although these cell lines are thought to express similar ganglionic-type nicotinic receptors. Functional responses in IMR-32 cells have been attributed mainly to ␣3␤4 receptors based on electrophysiological measurements (35) . IMR-32 and SH-SY5Y cells express receptor at Ͻ100 fmol͞mg protein (23, 37), whereas KX␣3␤4R2 cells express receptors at Ϸ8,000 fmol͞mg protein (25) . It is possible that the differences in potency are due to differences in fractional receptor activation requirements for membrane depolarization. This mechanism could also explain the differences in potency between the calcium and membrane potential assays for antagonists. In the case of agonists, it is possible that only a small fraction of receptors need be activated to depolarize the membrane (the fraction depending on receptor number), resulting in increased apparent potency. Conversely, antagonists would need to inhibit a much greater fraction of receptors to prevent depolarization, resulting in reduced apparent potency. This is a potentially important observation, as such depolarizations act as the triggering event for opening voltage-gated ion channels and other membrane potential-dependent processes.
Conclusions
Membrane potential fluorescence is a sensitive measure of nicotinic receptor functional response, giving data that is complementary to calcium fluorescence and radioisotopic ion flux methods. Further, membrane potential signals can be obtained in cell lines in which it has been difficult to measure responses with other functional assays. It affords robust signals and reproducible pharmacology for a variety of nicotinic receptor subtypes. Membrane potential fluorescence should prove a valuable tool for characterizing nicotinic receptor function and for discovering novel nicotinic agents.
